During his first term in office, President Trump’s FDA approved abortion pill manufacturer GenBioPro’s abbreviated new drug application, officially bringing the first generic mifepristone to the market. Six years later, his FDA has made the same mistake, approving a second generic by Evita Solutions.

If they believe the pro-life movement is not watching, they are sorely mistaken.

The approval of the Evita Solutions abbreviated new drug application comes swiftly on the heels of a promise by Department of Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary to review the safety of the name-brand Mifeprex, responding to a letter voicing the concerns of Republican attorneys general. This raises questions about just how approving a second generic mifepristone accelerates the administration’s “Make America Healthy Again.”

Kennedy, a........

© The Hill